• 1. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 2. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 3. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 4. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

Recent Advances in the Study of 2-(Chloromethyl)-6-methoxy-Pyridine (CAS: 405103-68-6) in Chemical Biology and Pharmaceutical Research

2-(Chloromethyl)-6-methoxy-Pyridine (CAS: 405103-68-6) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of pharmaceuticals and agrochemicals. Recent studies have highlighted its versatility as a building block for the construction of complex molecules with potential therapeutic applications. This research briefing provides an overview of the latest advancements involving this compound, focusing on its synthetic utility, biological relevance, and emerging applications in drug discovery.

In synthetic chemistry, 2-(chloromethyl)-6-methoxy-Pyridine has been employed as a precursor for the preparation of pyridine-based ligands and catalysts. A 2023 study published in the Journal of Organic Chemistry demonstrated its effectiveness in palladium-catalyzed cross-coupling reactions, enabling the efficient synthesis of functionalized pyridine derivatives. The electron-donating methoxy group at the 6-position was found to significantly influence the reactivity of the chloromethyl group at the 2-position, offering new possibilities for regioselective modifications.

Pharmaceutical research has particularly benefited from this compound's unique structural features. Recent investigations have explored its incorporation into kinase inhibitor scaffolds, with promising results in targeting various cancer-related pathways. A 2024 publication in Bioorganic & Medicinal Chemistry Letters reported the development of novel EGFR inhibitors using 2-(chloromethyl)-6-methoxy-Pyridine as a core structural element, showing improved selectivity profiles compared to existing therapeutics.

The compound's potential in central nervous system (CNS) drug development has also gained attention. Researchers at several academic institutions have utilized 405103-68-6 as a starting material for the synthesis of GABA receptor modulators, with preliminary in vivo studies demonstrating anxiolytic effects without the sedative side effects commonly associated with current treatments. These findings were presented at the 2023 International Symposium on Medicinal Chemistry and have since been under further investigation.

From a safety and pharmacokinetic perspective, recent ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) studies of derivatives containing the 2-(chloromethyl)-6-methoxy-Pyridine moiety have shown favorable metabolic stability and blood-brain barrier penetration properties. This makes the compound particularly valuable for CNS-targeted drug development programs. However, researchers note that careful consideration must be given to the reactivity of the chloromethyl group when designing prodrug strategies.

Looking forward, the applications of 2-(chloromethyl)-6-methoxy-Pyridine appear to be expanding beyond traditional pharmaceutical uses. Recent patent filings indicate growing interest in its incorporation into materials science applications, particularly in the development of functional polymers with antimicrobial properties. Additionally, its potential in agricultural chemistry is being explored, with several agrochemical companies investigating its derivatives as novel plant growth regulators.

In conclusion, 2-(chloromethyl)-6-methoxy-Pyridine (CAS: 405103-68-6) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, combined with the biological activity of its derivatives, ensures its ongoing relevance in drug discovery efforts. As synthetic methodologies advance and our understanding of structure-activity relationships deepens, we anticipate seeing more innovative applications of this compound in the coming years.

• 63071-03-4(2-Methoxy-6-methylpyridine)
• 100636-47-3(2-(Chloromethyl)-6-methoxy-4-methylpyridine)
• 1269418-09-8(6-methoxypicolinoyl chloride)
• 20045-67-4
• 123926-27-2(2-(Benzyloxy)-6-(chloromethyl)pyridine)
• 84641-07-6(PYRIDINE, 2-(CHLOROMETHYL)-6-PHENOXY-)
• 1060815-50-0(4-Bromo-2-(chloromethyl)-6-methoxypyridine)
• 1227595-34-7(4-(Chloromethyl)-2-methoxy-6-methylpyridine)
• 1361692-49-0(2-(chloromethyl)-6-(trifluoromethoxy)pyridine)
• 864264-99-3(2-(chloromethyl)-6-methoxy-pyridine hydrochloride)